�山ǿ�� News - tuberculosis

Study sheds light on how the immune system protects the body

webfull — Mon, 08 May 2023 13:19:14 +0000

First study of humans with a rare immunodeficiency reveals how the immune system protects the body against pathogens known to cause serious diseases, such as tuberculosis and COVID-19. The research involving �山ǿ��, paves the way for new therapies to treat autoimmune diseases, chronic inflammatory diseases, and new approaches to vaccine development.

Published: 8 May 2023

New study uncovers vast variation and significant deficits in tuberculosis care in urban India

webfull — Tue, 25 Sep 2018 18:13:00 +0000

On September 26, Heads of State will gather in New York at the United Nations (UN) General Assembly’s first-ever high-level meeting on tuberculosis (TB) to accelerate efforts to end TB and reach all affected people with prevention and care.

Published: 25 September 2018

Complete make-over in fight of multidrug-resistant tuberculosis

webfull — Fri, 07 Sep 2018 20:05:26 +0000

Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study led by Dr. Dick Menzies, senior scientist at the Research Institute of the �山ǿ�� Health Centre (RI-MUHC) in Montreal. These findings precipitated a complete overhaul of worldwide TB treatment guidelines, with the results of this work published today in the British medical journal The Lancet.

Published: 7 September 2018

Latent TB Treatment: Shorter is Better

webfull — Thu, 02 Aug 2018 13:38:59 +0000

Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the �山ǿ�� Health Centre (RI-MUHC) revealed that a shorter treatment was safer and more effective in children and adults compared to the current standard. These findings are published today in the New England Journal of Medicine.

Published: 2 August 2018

Beyond Killing Tuberculosis

webfull — Fri, 11 May 2018 19:11:41 +0000

Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease. However, this perspective has recently been challenged as scientists have taken a lesson from plant biologists about an ancient strategy involving the ability to “tolerate” rather than “resist” infection to maintain health. This concept, referred to as “disease tolerance”, provides an opportunity to develop new strategies that mitigate the consequences of infection.

Published: 11 May 2018

Re-programming innate immune cells to fight tuberculosis

webfull — Thu, 11 Jan 2018 17:33:33 +0000

Published: 11 January 2018

New MUHC study calls for targeted screening of high-risk healthcare workers for tuberculosis

webfull — Mon, 31 Jul 2017 17:48:53 +0000

Published: 31 July 2017

Simulated patient study sheds new light on antibiotic use in India

webfull — Thu, 25 Aug 2016 11:15:52 +0000

�山ǿ�� Newsroom

As a result of the overuse or misuse of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world’s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.

Published: 25 August 2016

Experts: World TB Day 2016 (March 24)

webfull — Tue, 22 Mar 2016 14:17:24 +0000

World TB Day is held each year on March 24th and aims to build public awareness for tuberculosis. A disease which despite being curable, remains a destructive epidemic in much of the world.

Published: 22 March 2016

$5M for Malaria, Tuberculosis Drug-discovery Research

webfull — Thu, 17 Dec 2015 20:34:47 +0000

University of Toronto and �山ǿ�� scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.

Published: 17 December 2015